[Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration].
Yokota
M
M
Department of Clinical Laboratory Medicine, Nagoya University Hospital.
Toyama
J
J
Ukai
M
M
Miyahara
T
T
Koide
M
M
Kato
R
R
Yasui
S
S
Sotobata
I
I
D000284:Administration, Oral; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000494:pharmacology; D001073:Aprindine / Q000493:pharmacokinetics / Q000494:pharmacology; D005424:Flecainide / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000493:pharmacokinetics / Q000494:pharmacology; D008012:Lidocaine / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000494:pharmacology; D008801:Mexiletine / Q000493:pharmacokinetics / Q000494:pharmacology; D010880:Piperidines / Q000493:pharmacokinetics / Q000494:pharmacology; D011405:Propafenone / Q000493:pharmacokinetics / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; D010880:Piperidines; D008801:Mexiletine; D001073:Aprindine; D011405:Propafenone; D008012:Lidocaine; C042288:pilsicainide; D005424:Flecainide; C024318:pirmenol; C032151:cifenline